Fair Value Measurement - Narratives (Details) - USD ($) |
Jun. 30, 2025 |
Jun. 03, 2025 |
Jun. 21, 2024 |
Jun. 20, 2024 |
Jul. 06, 2021 |
May 22, 2020 |
|---|---|---|---|---|---|---|
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis | ||||||
| Loan commitment assets | $ 76,091,000 | |||||
| Exercise price of warrants (in dollars per share) | $ 11.50 | |||||
| 2021 Convertible Note | Convertible Notes | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis | ||||||
| Principal amount | $ 122,868,000 | $ 100,000,000 | ||||
| SPA Warrant | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis | ||||||
| Loan commitment assets | $ 32,903,000 | |||||
| Level 3 | SPA Warrant | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis | ||||||
| Exercise price of warrants (in dollars per share) | $ 0.01 |
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Face (par) amount of debt instrument at time of issuance. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Fair value portion of loan receivable, including, but not limited to, mortgage loans held for investment, finance receivables held for investment, policy loans on insurance contracts. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|